TAKARA HOLDINGS INC.

NEWS RELEASE

This page introduces the press release provided to journalists.

2009

page top

2009.06.17

Takara Bio Inc. to supply RetroNectin^® to U.S. and Europe for multicentre clinical trials of gene therapy targeting X-linked Severe Combined Immunodeficiency (X-SCID)

2009.06.04

Takara Bio and Kohjin-bio form an alliance in the field of cell culture media

2009.05.12

Announcement of Takara Bio's mid-term management plan

2009.04.22

National Cancer Center in Japan gains a regulatory approval of the clinical research for HSV-TK "haplo add-back" gene therapy in treatment of leukemia

page top